Quoting from the November 18 posting:
"AURORA The Fitzsimons Redevelopment Authority announced four new members of its board of directors this week, additions officials say are part of a strategic refocusing of the 15-year-old organization.
'Our first tactic in refocus involves augmenting our board of directors with four of the area’s most well-known and successful leaders in the bioscience industry,' said Denise Brown, interim executive director of the FRA.
The new directors are: Donald M. Elliman, Jr., executive director of the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and member of the Children’s Hospital Colorado Board of Directors; William Freytag, PhD, former chairman and CEO of Myogen, Inc.; James C. T. Linfield, partner-in-charge of the Colorado office of Cooley LLP; David Perez, president and CEO of CaridianBCT, becoming TerumoBCT."
Link to the Aurora Sentinel